Download αPVP and MDPV Active Vaccine Attenuates Wheel Locomotor Behavior Introduction

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Bad Pharma wikipedia , lookup

Polysubstance dependence wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Medication wikipedia , lookup

Drug design wikipedia , lookup

Bilastine wikipedia , lookup

Prescription costs wikipedia , lookup

Drug interaction wikipedia , lookup

Pharmacognosy wikipedia , lookup

Anthrax vaccine adsorbed wikipedia , lookup

Smallpox vaccine wikipedia , lookup

Polio vaccine wikipedia , lookup

Gardasil wikipedia , lookup

Pharmaceutical industry wikipedia , lookup

Drug discovery wikipedia , lookup

Pharmacokinetics wikipedia , lookup

Non-specific effect of vaccines wikipedia , lookup

Theralizumab wikipedia , lookup

Vaccine wikipedia , lookup

Stimulant wikipedia , lookup

Neuropharmacology wikipedia , lookup

Psychopharmacology wikipedia , lookup

Transcript
αPVP and MDPV Active Vaccine Attenuates Wheel Locomotor Behavior
Brent R. Kisby1, Michael A. Taffe1
There have been several studies in the efficacy of different vaccines to
treat the abuse of methamphetamine (Miller, M et al 2015; 2013),
cocaine (Carrera MR et al 2000), and heroin (Scholsburg JE et al
2013).
Drug Vaccines
“Bath Salts” are a group of synthetic cathinones with the
phenylethylamine backbone. They are highly potent for both
serotonin and dopamine transporters. These synthetic
cathinones have been sold under the labels of “plant food”, “lab
certified”, “not for human consumption” and “bath salts”. They
also go by the terms “meow meow”, “flakka”, and “monkey
dust”. They are sold in headshops and were legal for the longest
time because the DEA could not schedule the analogs fast
enough. With a slight change in structure as indicated below,
each drug has their own properties that are more MDMA-like,
cocaine-like, or Methamphetamine-like.
unprotected
Brain
Blood
This study was to determine the role of “Bath Salt” vaccine
attenuating the stimulant properties of the two synthetic
psychostimulants.
Methods/Materials
•
Charles-Rivers Sprague-Dawley (n=36), 76 days old at start
of study
• Three groups: aPVP vaccine, MDPV vaccine, KLH control
Vaccine given at week 0
• Boosted on weeks 2 and 4
• Acute i.p dose of drug (0,.25,.5,1.0,5.0/ mg/kg) with 4 hour
run time
• Rectal temperature every hour pre-inection and at every
hour post initial drug challenge
Protected by
antibodies
Y
Vaccine and
boost
Y
Y Y
200
*
*
0
2h
3h
time Post-Injection
4h
KLH-MDPV veh
1400
KLH-MDPV (.25 mg/kg)
1200
KLH-mdpv0.5
1000
800
600
**
400
200
1h
aPVP vac
1400
Y Y
Y
Y
400
MDPV (5.0 mg/kg)
*
800
KLH-mdpv1.0
KLH-mdpv5.0
*
0
Results
Y Y
Y
Y
MDPV (1.0 mg/kg)
1000
KLH-MDPV
antibody
Brain
Blood
MDPV (0.5 mg/kg)
1200
600
MDPV (veh)
MDPV (0.25 mg/kg)
1400
1h
Drug
molecule
Y
Wheel Rotations
“Bath Salts” are a group of synthetic cathinones with similar
psychoactive properties like methamphetamine. The compounds used
in this study are MDPV (Methylenedioxypyrovalerone) and aPVP
(alpha-pyrrolidinovalerophenone). These compounds are highly potent
for the Dopamine transporter and moderately potent for the Serotonin
transporter (Simmler et al 2012).
“Bath Salts”: Not
Really for your Bath
MDPV vac
Wheel Rotations
Introduction
Scripps Research Institute, La Jolla, CA 92121
Wheel Rotations
1The
2h
3h
time Post-Injection
4h
Fig. 3: Quarter wheel rotations in MDPV
actute i.p challenges from 0-5.0 mg/kg
αPVP (veh)
αPVP (0.25 mg/kg)
1200
αPVP (0.5 mg/kg)
1000
αPVP (1.0 mg/kg)
αPVP (5.0 mg/kg)
800
*
600
400
200
Conclusions
*
•
MDPV/aPVP vaccine show efficacy in decreasing the stimulant
locomoter effects of both drugs in low to moderate doses, but not the
high dose
Data mirrors other studies of drug vaccine because there is no
protection at the highest dose
0
Adopted from Julian’s Primer of Drug Action © 2014 pg. 230
*
1h
2h
3h
time Post-Injection
4h
•
Dopamine
“Bath Salts”
MDMA
methylone
Fig. 1: level of anti-body titer detected by
ELISA optical density from rat plasma. The
arrows indicate when each rat was boosted
with their respective vaccine. Bettween week
6 and week 10 is when the drug study
occurred.
4-MMC
Cathinone structure
1400
1200
1000
800
600
400
200
0
*
**
KLH-aPVP-veh
KLH-aPVP0.25
KLH-alpha0.5
KLH-aPVP1.0
KLH-alpha5.0
1.
2.
*
3.
4.
5.
1h
2h
3h
time Post-Injection
4h
Fig. 2: Quarter wheel rotations for aPVP
actute i.p challenges from 0-5.0 mg/kg
5-IT
(5-(2-Aminopropyl)indole)
methedrone
Wheel Rotations
KLH-aPVP
methcathinone
6.
Citations
Advokat, Claire D., Joseph E. Comaty, and Robert M. Julien. Julien's Primer of Drug Action: A Comprehensive Guide to the
Actions, Uses, and Side Effects of Psychoactive Drugs. 13th ed. New York: Worth, 2014. Print.
Carrera, M. R. A., J. A. Ashley, B. Zhou, P. Wirsching, G. F. Koob, and K. D. Janda. "Cocaine Vaccines: Antibody Protection
against Relapse in a Rat Model." Proceedings of the National Academy of Sciences 97.11 (2000): 6202-206. Web.
Miller, Michelle L., Amira Y. Moreno, Shawn M. Aarde, Kevin M. Creehan, Sophia A. Vandewater, Brittani D. Vaillancourt, M.
Jerry Wright, Kim D. Janda, and Michael A. Taffe. "A Methamphetamine Vaccine Attenuates Methamphetamine-Induced
Disruptions in Thermoregulation and Activity in Rats." Biological Psychiatry 73.8 (2013): 721-28. Web.
Miller, M.l., S.m. Aarde, A.y. Moreno, K.m. Creehan, K.d. Janda, and M.a. Taffe. "Effects of Active Anti-methamphetamine
Vaccination on Intravenous Self-administration in Rats." Drug and Alcohol Dependence 153 (2015): 29-36. Web.
Schlosburg, J. E., L. F. Vendruscolo, P. T. Bremer, J. W. Lockner, C. L. Wade, A. A. K. Nunes, G. N. Stowe, S. Edwards, K.
D. Janda, and G. F. Koob. "Dynamic Vaccine Blocks Relapse to Compulsive Intake of Heroin." Proceedings of the National
Academy of Sciences 110.22 (2013): 9036-041. Web.
Simmler, Ld, Ta Buser, M. Donzelli, Y. Schramm, L-H Dieu, J. Huwyler, S. Chaboz, Mc Hoener, and Me Liechti.
"Pharmacological Characterization of Designer Cathinones in Vitro." British Journal of Pharmacology Br J Pharmacol 168.2
(2012): 4
Acknowledgements
IFunding supported by NIDA.
Serotonin (5-HT)
www.postersession.com